Topics: CAR-T

Tim Card and his wife, Tricia, walk the hallways of Penn State Cancer Institute after he receives CAR-T cell therapy infusion. Their backs are toward and the camera, and they are silhouetted against a window. Tricia puts her hand on his back. Tim is pushing an IV pole, and an IV bag with medication hangs from the pole. A rainbow is painted on the window.

Unintentional pioneer

Jan 1, 2019

Mount Joy resident Tim Card made history at Penn State Cancer Institute as the first recipient of CAR-T therapy. Follow his journey to remission.

A graphic of a large, round CAR-T cell with oval-shaped protrusions touching a cancer cell. The cancer cell is round and has tentacles resembling an octopus.

Lifesaving lymphoma treatment comes to Penn State Cancer Institute

Dec 12, 2018

For people with an aggressive form of non-Hodgkin lymphoma, treatments can be limited. Enter a new treatment called Yescarta. Yescarta, or axicabtagene ciloleucel, can be nothing short of “miraculous” for these patients.

The glass-fronted Penn State Cancer Institute is seen in Hershey, PA.

Penn State Cancer Institute now offering CAR-T cell therapy

Jun 6, 2018

Penn State Cancer Institute is now the first and only oncology center in central Pennsylvania to offer patients CAR T-cell therapy, a cutting-edge treatment that has been successful treating a common type of lymphoma.